InsiderClue
Stocks · Health care · Pharmaceutical Preparations

MARAVAI LIFESCIENCES HOLDINGS, INC.

MRVI Clue Score31
United States Fiscal year ends December CIK 0001823239
$7.44 +3.19% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $7.44 −80.85% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 20 Nov 2020. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back. P/E and P/FCF are the market value over the last full fiscal year's net income or free cash flow, as public on each day, so they step once a year when the annual report comes out. A hatched band marks a stretch with none: a year of net loss, or of cash burnt.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2019Revenue143.1Operating income24.0Net income−4.5EPS, diluted−0.03Fiscal year 2020Revenue284.1 +98.5%Operating income119.9Net income89.0EPS, diluted2.36Fiscal year 2021Revenue799.2 +181.3%Operating income554.6Net income182.0 +104.6%EPS, diluted1.56Fiscal year 2022Revenue883.0 +10.5%Operating income574.2Net income220.2 +21.0%EPS, diluted1.67Fiscal year 2023Revenue288.9 −67.3%Operating income−31.6Net income−119.0 −154.1%EPS, diluted−0.90Fiscal year 2024Revenue259.2 −10.3%Operating income−235.6Net income−144.8EPS, diluted−1.05Fiscal year 2025Revenue185.7 −28.3%Operating income−215.3Net income−130.8EPS, diluted−0.90
FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue 143.1 284.1 799.2 883.0 288.9 259.2 185.7
Growth +98.5% +181.3% +10.5% −67.3% −10.3% −28.3%
Operating income 24.0 119.9 554.6 574.2 −31.6 −235.6 −215.3
Net income −4.5 89.0 182.0 220.2 −119.0 −144.8 −130.8
Growth +104.6% +21.0% −154.1%
EPS, diluted −0.03 2.36 1.56 1.67 −0.90 −1.05 −0.90

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Gross marginOperating marginNet margin
Fiscal year 2019Operating margin16.8%Net margin−3.1%Free cash flow margin4.9%Fiscal year 2020Operating margin42.2%Net margin31.3%Free cash flow margin44.6%Fiscal year 2021Operating margin69.4%Net margin22.8%Free cash flow margin44.3%Fiscal year 2022Operating margin65.0%Net margin24.9%Free cash flow margin58.8%Fiscal year 2023Gross margin48.5%Operating margin−11.0%Net margin−41.2%Free cash flow margin21.0%Fiscal year 2024Gross margin41.8%Operating margin−90.9%Net margin−55.9%Free cash flow margin−8.6%Fiscal year 2025Gross margin18.3%Operating margin−115.9%Net margin−70.4%Free cash flow margin−38.1%
FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Gross margin n/a n/a n/a n/a 48.5% 41.8% 18.3%
Operating margin 16.8% 42.2% 69.4% 65.0% −11.0% −90.9% −115.9%
Net margin −3.1% 31.3% 22.8% 24.9% −41.2% −55.9% −70.4%
Free cash flow margin 4.9% 44.6% 44.3% 58.8% 21.0% −8.6% −38.1%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2019Operating cash flow24.1Capital expenditure−17.1Free cash flow7.0Buybacks0.0Fiscal year 2020Operating cash flow152.2Capital expenditure−25.4Free cash flow126.8 +1,719.7%Buybacks−33.7Fiscal year 2021Operating cash flow368.6Capital expenditure−14.9Free cash flow353.7 +179.0%Buybacks0.0Fiscal year 2022Operating cash flow536.0Capital expenditure−17.1Free cash flow518.9 +46.7%Buybacks0.0Fiscal year 2023Operating cash flow126.2Capital expenditure−65.6Free cash flow60.7 −88.3%Fiscal year 2024Operating cash flow7.5Capital expenditure−29.7Free cash flow−22.2 −136.6%Fiscal year 2025Operating cash flow−57.6Capital expenditure−13.1Free cash flow−70.7
FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow 24.1 152.2 368.6 536.0 126.2 7.5 −57.6
Capital expenditure −17.1 −25.4 −14.9 −17.1 −65.6 −29.7 −13.1
Free cash flow 7.0 126.8 353.7 518.9 60.7 −22.2 −70.7
Growth +1,719.7% +179.0% +46.7% −88.3% −136.6%
Buybacks 0.0 −33.7 0.0 0.0 n/a n/a n/a

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
CashTotal debt
Fiscal year 2019Cash24.7Shareholders’ equity144.6Fiscal year 2020Cash236.2Total debt534.6Net cash (debt)−298.4Shareholders’ equity88.5Debt to equity6.04Fiscal year 2021Cash551.3Total debt530.6Net cash (debt)20.7Shareholders’ equity315.5Debt to equity1.68Fiscal year 2022Cash632.1Total debt527.4Net cash (debt)104.7Shareholders’ equity545.2Debt to equity0.97Fiscal year 2023Cash575.0Total debt524.1Net cash (debt)50.8Shareholders’ equity416.8Debt to equity1.26Fiscal year 2024Cash322.4Total debt295.9Net cash (debt)26.5Shareholders’ equity325.3Debt to equity0.91Fiscal year 2025Cash216.9Total debt291.8Net cash (debt)−74.9Shareholders’ equity212.4Debt to equity1.37
FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash 24.7 236.2 551.3 632.1 575.0 322.4 216.9
Total debt n/a 534.6 530.6 527.4 524.1 295.9 291.8
Net cash (debt) n/a −298.4 20.7 104.7 50.8 26.5 −74.9
Shareholders’ equity 144.6 88.5 315.5 545.2 416.8 325.3 212.4
Debt to equity n/a 6.04 1.68 0.97 1.26 0.91 1.37

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Ratios

Percentages worked out from the filed figures; debt to equity in times. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2019 31 Dec 2019 FY2020 31 Dec 2020 FY2021 31 Dec 2021 FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Margins
n/a n/a n/a n/a 48.5% 41.8% 18.3%
16.8% 42.2% 69.4% 65.0% −11.0% −90.9% −115.9%
−4.1% 28.8% 66.4% 62.5% 213.8% −100.9% −126.5%
−3.1% 31.3% 22.8% 24.9% −41.2% −55.9% −70.4%
4.9% 44.6% 44.3% 58.8% 21.0% −8.6% −38.1%
Spending
2.5% 3.3% 1.9% 2.1% 6.0% 7.4% 9.4%
33.8% 33.2% 12.5% 14.6% 52.4% 62.4% 78.1%
12.0% 8.9% 1.9% 1.9% 22.7% 11.4% 7.1%
n/a 3.5% 11.6% 11.0% 122.4% n/a n/a
Returns
−3.1% 100.5% 57.7% 40.4% −28.6% −44.5% −61.6%
n/a 7.0% 9.5% 9.6% −8.0% −14.4% −17.0%
Balance and payout
n/a 6.04 1.68 0.97 1.26 0.91 1.37
n/a 87.8% 71.6% 60.3% 46.9% 42.8% 51.6%
0.0% 26.5% 0.0% 0.0% n/a n/a n/a